鲁抗医药 Lukang Pharmaceutical 
山东鲁抗医药股份有限公司是国家大型生物制药企业，国家重要的抗生素研发、生产基地，国家重点高新技术企业，拥有国家级企业技术中心。鲁抗医药A股（600789）股票于1997年2月在上海证券交易所挂牌上市，现有资产38亿元，占地近4000亩，拥有5家全资子公司、7家控股子公司、1家参股公司，员工6500余人，其中各类专业技术人员3100余人。

鲁抗以发展生态医药、服务人类健康为使命，以专业领先，行业领跑、基业长青为愿景，坚持诚信、创新、共赢的核心价值观，大力创建资源节约型和环境友好型企业，制造安全高效的药品，保障病患者健康，造福自然，造福人类。

鲁抗医药拥有年产各类微生物发酵及半合成原料药15000吨、粉针30亿支、片剂100亿片、胶囊50亿粒、水针2亿支、大容量注射剂1.5亿瓶的生产能力，主要产品有人用药、动植物药等500余个品种，已通过ISO9001质量体系认证、ISO14000环境体系认证和OSHMS职业健康安全体系认证，青霉素钠原料药及粉针获得国家质量金奖，酒石酸泰乐霉素、大观霉素原料药获得欧盟CEP证书，大观霉素通过德国cGMP认证，AIV、盐酸大观霉素均通过美国FDA认证。鲁抗产品畅销全国，远销亚洲、欧洲、非洲、美洲40多个国家和地区，年出口创汇过亿美元。

鲁抗以科技为先导，走科技兴企之路，运用现代生物技术，生产经营抗生素类、氨基酸类、心脑血管类、半合成抗生素类原料药，生物药品以及相关制剂、输液、中成药、医药中间体、动物保健用抗生素、淀粉、葡萄糖等。

“鲁抗”牌商标是“中国驰名商标”，被评为“商务部重点培育和发展的出口名牌”，先后获得了“全国质量效益型先进企业”、“全国用户满意企业”、“全国医药优秀企业”等荣誉称号，2009年被认定为国家级高新技术企业；2011年鲁抗研发中心被认定为国家级企业技术中心，2012年被确定为山东省科技兴贸出口创新基地。

“十二五”期间，鲁抗围绕发展战略，以市场为导向，以体制机制和管理创新为保障，以科技创新和技术进步为动力，优化资源配置，提升管理能力，打造生物制药、生物制品、生物基因制药三条产业链，大力发展鲁抗（人用）医药、鲁抗动保、环境科技、鲁抗生物四大板块，建设鲁抗医药、科技、生物制造、合成四大产业园区，努力培育和提升企业核心竞争力，使鲁抗跻身于国内一流制药企业行列。

As a large stated owned company and one of the major production bases for antibiotics in China, Shandong Lukang Pharmaceutical Group Co., Ltd. owns total assets of RMB 3.8 billion Yuan, 9 subsidiaries--one listed company on Shanghai Stock Exchange among them. Total employee is over 7000.

Lukang Pharma (formerly Jining Antibiotic Factory) was founded in 1966. In 1984, Director’s Responsibility System was adopted and was changed to stock share company in 1992. In 1997, Shandong Lukang Pharmaceutical Co., Ltd was listed on Shanghai Stock Exchange. Lukang Brand is China well-known trademark and was recognized by ShandongProvince as priority cultivation world famous brand. From 2001, Lukang was certified by ISO14001, OSHMS and GMP for all the workshops.In 2005, Lukang brand was recognized by the Ministry of Commerce of the People’s Republic of China as a “Chinese Export Brand for Priority Cultivation and Development”.

Major products of Lukang Pharma. are: antibiotics, semi-synthetic antibiotics and their finished products for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starch, glucose and amino acid. Its products have been exporting to more than 40 countries districts all over the world and annual exporting value is over USD40 milllion. By adjusting the composition of the products and optimized the product structure, three series of product chain for 6-APA, 7-ACA and 7-ADCA have been formed in Lukang and Lukang Pharma. has changed successfully from a traditional antibiotics plant to a semi-synthetic antibiotics manufacturer.

Facing the future and with a view to establish a long lasting great enterprise, Lukang Pharma. will devote itself to the career of human health care and contribute more and more to the society.